Inventor · disambiguated record
Marianne Bernice Ashford
Also filed as: ASHFORD MARIANNE · ASHFORD MARIANNE BERNICE
6 granted patents·3 pending applications·10 citations·filing 2003–2023
76Inventor score
Files withASTRAZENECA AB9
Top patents by PatentIndex Score
9 records- 0191US10888624B2Therapeutic dendrimersASTRAZENECA AB·Filed 2019·Granted Jan 12, 2021·3 cites·18 claims
- 0289US11717574B2Therapeutic dendrimersASTRAZENECA AB·Filed 2020·Granted Aug 8, 2023·2 cites·23 claims
- 0385US10314920B2Therapeutic dendrimersASTRAZENECA AB·Filed 2018·Granted Jun 11, 2019·5 cites·16 claims
- 0477US2024115716A1Therapeutic dendrimersASTRAZENECA AB·Filed 2023·Application pending·0 cites
- 0556US10047072B2Therapeutic polymeric nanoparticles and methods of making and using sameASTRAZENECA AB·Filed 2014·Granted Aug 14, 2018·0 cites·5 claims
- 0653US10577351B2Therapeutic polymeric nanoparticles and methods of making and using sameASTRAZENECA AB·Filed 2018·Granted Mar 3, 2020·0 cites·7 claims
- 0751US2022273807A1Conjugates for use in methods of treating cancerASTRAZENECA AB·Filed 2019·Application pending·0 cites
- 0843US7820679B2N-(-3-methoxy-5-methylpyrazin-2-yl)-2-(4-′1,3,4-oxadiazol-2-yl-phenyl)pyridine-3 sulphonamide as an anticancer agentASTRAZENECA AB·Filed 2003·Granted Oct 26, 2010·0 cites·9 claims
- 0934US2011003831A1N-(-3-methoxy-5-methylpyrazin-2-yl)-2-(4-'1,3,4-oxadiazol-2-yl!phenyl)pyridine-3 sulphonamide as an anticancer agentASTRAZENECA AB·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →